Organization: Health Canada
Year: 2024
Month: October
Request Number: A-2024-000788
Request Summary: Adverse Drug Reaction (ADR) for Mesalamine. Report number: E2B_07260714. ADRs for VYVANSE. Report numbers: 001096896, 001099547, 001097667, 001099106. ADRs for GAMMAGARD LIQUID. Report numbers: 001100896, 001100852, 001095982, 001100737, 001097968.
Disposition: Disclosed in part
Number of pages: 70